Experimental Leukemia and Mammary Cancer: Induction, Prevention, Cure, Huggins
The book Experimental Leukemia and Mammary Cancer: Induction, Prevention, Cure, Charles Brenton Huggins is published by ... Induction of Leukemia Leukemia in S-D Rat Leukemia in L-E Rat Recognition of Leukemia Transplantation of Blood from Leukemic ... Induction of Leukemia by Intravenous Injection of 7,12-DMBA in Mouse Induction of Leukemia by Feeding 7,12-DMBA in Mouse ... Types of Hydrocarbon-Induced Leukemia Extinction of Leukemia by Endocrine Methods Erythroleukemia, Anemia, and Erythropoietin 9 ...http://press.uchicago.edu/ucp/books/book/chicago/E/bo3622967.html
Leukemia, Experimental | CTD
Leukemia, Experimental Synonyms Animal Leukemia Model , Animal Leukemia Models , Experimental Leukemia , Experimental Leukemias ... Leukemia Model, Animal , Leukemia Models, Animal , Leukemias, Experimental Definition Leukemia induced experimentally in ... Leukemia ← Leukemia, Experimental 2.. Diseases ← Neoplasms ← Neoplasms, Experimental ← Leukemia, Experimental Top ↑ Descendants ...http://ctdbase.org/detail.go?type=disease&acc=MESH%3AD007942
"Evidence of viral implication in experimental leukemia induced by n-ni" by N Imamura
Imamura, N, "Evidence of viral implication in experimental leukemia induced by n-nitrosobutylurea in mice." (1973). Subject ... Evidence of viral implication in experimental leukemia induced by n-nitrosobutylurea in mice. ...https://mouseion.jax.org/ssbb1973/1890/
Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia
... ... Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia, Voprosy ... bone marrow and liver tissue of rats with experimental leukosis. Scvalene was increased in kidney tissue. Simultaneous ... were studied in lymphoid tissues as well as in liver and kidney tissues of normal rats and the animals with Shvetz experimental ...http://pbmc.ibmc.msk.ru/index.php/en/article/PBMC-1983-29-3-64-en
Experimental treatment developed at UCLA eradicates acute leukemia in mice | PressReleasePoint
The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread. ... A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center has developed an experimental treatment that ... eradicates an acute type of leukemia in mice without any detectable toxic side effects. ... www.pressreleasepoint.com/experimental-treatment-developed-ucla-eradicates-acute-leukemia-mice' class='active',Experimental ...http://www.pressreleasepoint.com/experimental-treatment-developed-ucla-eradicates-acute-leukemia-mice
Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute...
... in acute leukemia (AL) with biochemical markers - "N-terminal pro brain natriuretic peptide" (NT-proBNP), cardiac troponin T ( ... markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia. ... of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia ...http://exp-oncology.com.ua/article/395/biochemical-markers-and-assessment-of-cardiotoxicity-during-preparative-regimen-and-hematopoietic-cell-transplantation-in-acute-leukemia
Alterations in composition of sterols and in properties of erythrocyte membranes in rats with Shvetz experimental leukemia and...
Alterations in composition of sterols and in properties of erythrocyte membranes in rats with Shvetz experimental leukemia and ... Alterations in composition of sterols and in properties of erythrocyte membranes in rats with Shvetz experimental leukemia and ... increased in erythrocyte membranes of rats with Shvetz experimental leukosis. At the same time, osmotic stability of ...http://pbmc.ibmc.msk.ru/index.php/en/article/PBMC-1983-29-3-67-en
Phase I trial finds experimental drug safe in treating chronic lymphocytic leukemia | EurekAlert! Science News
... an experimental monoclonal antibody-based drug, measurably inhibited the 'stemness' of chronic leukemia cancer (CLL) cells -- ... Phase I trial finds experimental drug safe in treating chronic lymphocytic leukemia Cirmtuzumab targets key cancer stem cell ... Phase I trial finds experimental drug safe in treating chronic lymphocytic leukemia. University of California - San Diego ... an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer (CLL) cells -- ...https://www.eurekalert.org/pub_releases/2018-06/uoc--pit053018.php
More Than a Third of High-Risk Leukemia Patients Respond To An Experimental New Drug - Healthcanal.com : Healthcanal.com
More Than a Third of High-Risk Leukemia Patients Respond To An Experimental New Drug. ... In more than a third of participants, the leukemia was completely cleared from the bone marrow, and as a result, many of these ... A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising ... Children Who Develop Acute Lymphoblastic Leukemia May Have Dysregulated Immune Function At Birth ...https://www.healthcanal.com/cancers/34790-more-than-a-third-of-high-risk-leukemia-patients-respond-to-an-experimental-new-drug.html
"Chemotherapy of experimental meningeal leukemia. Abstr." by F M. Schabel, T P. Johnston et al.
Schabel, F M.; Johnston, T P.; Caleb, G S.; Montgomery, J A.; Laster, R.; and Skipper, H E., "Chemotherapy of experimental ... meningeal leukemia. Abstr." (1963). Subject Strain Bibliography 1963. 918. https://mouseion.jax.org/ssbb1963/918 ...https://mouseion.jax.org/ssbb1963/918/
Deadly Leukemia Sent Into Remission By Experimental Treatment
... by Florian Rosado June 25, 2015. ... A small pilot study has shown that a new experimental treatment approach for a rare, deadly form of leukemia can put the ... Although this experimental approach did not cure the patients, it did send them all into remission. ... The pilot study involved eight patients with T-cell prolymphocytic leukemia, an aggressive cancer that is extremely difficult ...https://www.reliawire.com/deadly-leukemia-sent-into-remission-by-experimental-treatment/
IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine | Experimental oncology
... the frequency of IGHV3-21 gene usage and its clinical significance for patients with B-cell chronic lymphocytic leukemia ... IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine. Abramenko I., Bilous N.I., Kryachok I ... chronic lymphocytic leukemia, IGHV3-21, immunoglobulin variable heavy chain gene, prognostic factor. ... the frequency of IGHV3-21 gene usage and its clinical significance for patients with B-cell chronic lymphocytic leukemia (CLL) ...http://exp-oncology.com.ua/article/401/ighv3-21-gene-expression-in-patients-with-b-cell-chronic-lymphocytic-leukemia-in-ukraine
Study Information for: "Treatment with an experimental drug in patients with newly diagnosed Acute Lymphoblastic Leukemia." -...
Treatment with an experimental drug in patients with newly diagnosed Acute Lymphoblastic Leukemia. ... Treatment with an experimental drug in patients with newly diagnosed Acute Lymphoblastic Leukemia.. ... treatment with blinatumomab has on BCR/ABL negative Acute Lymphoblastic Leukemia. ...http://www.wakehealth.edu/BeInvolved/StudyInfo.aspx?study=IRB00027899&title=Treatment%20with%20an%20experimental%20drug%20in%20patients%20with%20newly%20diagnosed%20Acute%20Lymphoblastic%20Leukemia
"Experimental investigations in murine akm leukemia." by E Nastac, B Anagnoste et al.
Nastac, E; Anagnoste, B; and Balmus, G, "Experimental investigations in murine akm leukemia." (1963). Subject Strain ...https://mouseion.jax.org/ssbb1963/1232/
Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor...
Leukemia, Experimental / metabolism. Lymphocyte Activation*. Lymphokines / analysis, metabolism, physiology*. Mice. Mice, ...http://www.biomedsearch.com/nih/Role-N-acetyl-D-galactosamine/3897376.html
Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapy.
Acute leukemia is a heterogeneous tumor with respect to cellular proliferation and is sensitive to positive and negative growth ... Leukemia / drug therapy*, pathology. Leukemia, Experimental / drug therapy. Rats. Grant Support. ID/Acronym/Agency: CA-066973/ ... Acute leukemia is a heterogeneous tumor with respect to cellular proliferation and is sensitive to positive and negative growth ... Our in vivo studies of timed sequential chemotherapy in human leukemia demonstrate than an increase in tumor labeling index (LI ...http://www.biomedsearch.com/nih/Recruitment-quiescent-tumor-by-humoral/7159763.html
New Research on Cutaneous Lymphomas
Experimental Leukemia: History, Biology and Genetics. 02.. Cancer Metastasis Research: Pathological Insight. ...https://www.novapublishers.com/catalog/product_info.php?products_id=4772
Charlotte Friend, PhD, Papers, 1935-1987 | Icahn School of Medicine
Leukemia, Experimental. Mount Sinai School of Medicine. Graduate School of Biological Sciences: Box 39-40. National Academy of ... Human Leukemia--Articles; Clippings; Organizational meeting NCI Acute Leukemia Task Force, Leukemia Etiology Subgroup; " ... Friend C. "Experimental studies on a virus-induced leukemia of mice," 1960. ... Friend C. "Leukemia of Adult Mice Caused by a Transmissible Agent," in Annals of the NY Academy of Sciences, v.68, ART.2, Oct. ...http://icahn.mssm.edu/about/ait/archives/collection/charlotte-friend
Möglichkeiten und Grenzen internistischer Behandlung Krebskranker | SpringerLink
On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother Rep 55: 1-111Google ... Skipper HE, Schabel FM, Wilcox WS (1964) Experimental evaluation of potential anticancer agents. XII. ...https://link.springer.com/chapter/10.1007/978-3-642-75831-7_8
Neoadjuvant Versus Adjuvant Chemotherapy in Invasive Bladder Cancer | Springer for Research & Development
On the criteria and kinetics associated with curability of experimental leukemia. Cancer Chemother Rep 35:1-9PubMedGoogle ... Skipper HE, Schabel FM, Wilcox WS (1964) Experimental evaluation of potential anticancer agents. XII. ...https://rd.springer.com/chapter/10.1007/978-3-642-84583-3_18
2 Experimental Drugs Show Promise for Rare Pancrea... ( By Maureen Salamon HealthDay Rep...)
10 issue of the New England ...,2,Experimental,Drugs,Show,Promise,for,Rare,Pancreatic,Cancer,medicine,medical news today,latest ... Experimental Test May Spot Prostate Cancer Earlier, More Accurately. 11. Experimental Leukemia Drug Proves a Slam Dunk. ... Experimental vaccine sets sights on lung cancer. 7. Experimental Drug Raises Good Cholesterol Levels in Early Trial. 8. UT ... Experimental approach may improve healing of diabetic wounds and bed sores. 2. Study raises safety concerns about experimental ...http://www.bio-medicine.org/medicine-news-1/2-Experimental-Drugs-Show-Promise-for-Rare-Pancreatic-Cancer-79123-1/
Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial - TheStreet
... experimental leukemia drug vosaroxin underwent a miraculous transformation during a Sunday morning press briefing at the ... Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial. Sunesis' experimental leukemia drug vosaroxin underwent a ... SAN FRANCISCO (TheStreet) -- Sunesis Pharmaceuticals' (SNSS) experimental leukemia drug vosaroxin underwent a miraculous ... Vosaroxin should be considered a new standard of care for elderly patients with relapsed acute myeloid leukemia, based on a ...https://www.thestreet.com/story/12976752/1/sunesis-spin-doctor-tiptoes-around-failed-leukemia-drug-trial.html
SFB 1074 - Ulm University
SFB 1074 - Experimental Models and Clinical Translation in Leukemia First Funding Period: 01.07.2012 - 30.06.2016. Second ... functional characterization of leukemia samples from patients with acute and chronic leukemia and/or human-derived experimental ... Projects in Group A use a broad spectrum of physiologically relevant in vitro and in vivo experimental systems to investigate ... It is hoped that this approach will substantially contribute to improved understanding of leukemia biology, and, importantly, ...https://www.uni-ulm.de/?id=41680
PDB 1pvl structure summary ‹ Protein Data Bank in Europe (PDBe) ‹ EMBL-EBI
Is LukS-PV a novel experimental therapy for leukemia? Shan et al. (2017) ...http://www.ebi.ac.uk/pdbe/entry/pdb/1PVL
Lloyd J. Old - Wikipedia
1964 Dec 5;2(7371): 1207-9. Old LJ, Boyse EA, Stockert E. Antigenic properties of experimental leukemias. I. Serological ... First coined TL (for "thymus-leukemia" antigen in mice) then later as the Ly series (originally named Ly-A and Ly-B and later ... Boyse EA, Old LJ, Luell S. Genetic determination of the TL (thymus-leukemia) antigen in the mouse. Nature 1964; 201:779. Boyse ... Introduced Bacille Calmette-Guérin (BCG), the tuberculosis vaccine, into experimental cancer research as a way to stimulate non ...https://en.wikipedia.org/wiki/Lloyd_J._Old